Masanori Watanabe is the founder of Scohia Pharma. Scohia Pharma has raised $25M in total funding. Latest round: Series A. Backed by Beyond Next Ventures.
Masanori Watanabe is the President & CEO of Scohia Pharma, a drug discovery startup established in 2017 through a carve-out from Takeda Pharmaceutical Co. Scohia Pharma focuses on the research and development of small- and medium-molecule therapeutics, primarily for metabolic, endocrine, and cardiovascular diseases, and has pipelines ranging from lifestyle-related to rare diseases. The company recently raised JPY 3 billion in a financing round.
Full founder directory · Investor directory · Company funding database · Fundraising library